Chlorhexidine caps to prevent bloodstream infections in hemodialysis
Part of Infections clinical trials.
This trial tests whether using special caps with chlorhexidine on dialysis catheters can help prevent serious bloodstream infections. If you have kidney failure and use a tunneled central line for dialysis, this study may be an option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have kidney failure and need a tunneled central line for hemodialysis.
- You have not had a bloodstream infection in the last 21 days.
- You are not allergic to chlorhexidine, nylon, or polypropylene.
- You can understand and agree to participate in the study.
- You are not currently on an end-of-life care plan or have a cognitive or intellectual disability that would prevent participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a liquid that is put into the dialysis catheter after each session to prevent infections that can happen through the catheter. It is designed for children up to age 18 who need hemodialysis through a catheter.
This study tests a new type of hemodialysis catheter (a tube for cleaning your blood) that has a special coating to reduce clotting and blockages. It compares how well this new catheter works compared to similar catheters used in the past.
This trial studies how to make central lines safer by testing different ways to secure them and what caps to use. It is for people who need a central line, including those with cancer, and focuses on preventing infections.
This study tests a new approach to prevent infections on central venous catheters (thin tubes inserted into large veins) in hospital intensive care units. Researchers will study catheters that already show signs of bacterial growth to understand how to better protect patients from catheter-related infections.
This trial tests whether using a special antiseptic solution (Irrisept) when removing a urinary catheter can lower the chance of getting a urinary tract infection. It is for people visiting a urology clinic for catheter removal who are not already on antibiotics.
This trial tests whether taking preventive antibiotics (or a placebo sugar pill) can lower the risk of infections in people who receive hemodialysis through a catheter. It may help protect you from serious catheter-related infections, but you must be able to follow the study’s medicine and consent rules.
Hear when a new Vascular Access Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.